This Henry Schein Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Baird analyst Jeff Johnson upgraded Henry Schein Inc (NASDAQ:HSIC) from Neutral to Outperform and raised the price target from $78 to $100. Henry Schein shares closed at $79.57 on Friday. See how other analysts view this stock.
• Keybanc analyst Craig Mailman upgraded Macerich Co (NYSE:MAC) from Sector Weight to Overweight and announced a $25 price target. Macerich shares closed at $20.30 on Friday. See how other analysts view this stock.
• Mizuho analyst Uy Ear upgraded ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) from Neutral to Outperform and raised the price target from $29 to $35. ACADIA Pharmaceuticals shares closed at $23.99 on Friday. See how other analysts view this stock.

Considering buying HSIC stock? Here’s what analysts think:

Photo via Shutterstock